Natural infection in anopheline species and its implications for autochthonous malaria in the Atlantic forest in Brazil

Background: a descriptive study was carried out in an area of the atlantic forest with autochthonous malaria in the parelheiros subdistrict on the periphery of the municipality of são paulo to identify anopheline fauna and anophelines naturally infected with plasmodium as well as to discuss their role in this peculiar epidemiological context. methods. entomological captures were made from may 2009 to april 2011 using shannon traps and automatic cdc traps in four areas chosen for their different patterns of human presence and incidences of malaria (anthropic zone 1,anthropic zone 2,transition zone and sylvatic zone). natural plasmodium infection was detected by nested pcr based on amplification of the 18s rrna gene. results: in total,6,073 anophelines were collected from may 2009 to april 2011,and six species were identified in the four zones. anopheles cruzii was the predominant species in the three environments but was more abundant in the sylvatic zone. anopheles (kerteszia) cruzii specimens from the anthropic and sylvatic zones were positive for p. vivax and p. malariae. an. (ker.) bellator,an. (nys.) triannulatus,an. (nys.) strodei,an. (nys.) lutzi and an. (ano) maculipes were found in small numbers. of these,an. (nys.) triannulatus and an. (nys.) lutzi,which were collected in the anthropic zone,were naturally infected with p. vivax while an. (nys.) triannulatus from the anthropic zones and an. (nys.) strodei from the transition zone were positive for p. malariae. conclusion: these results confirm that anopheles (kerteszia) cruzii plays an important role as a major plasmodium vector. however,the finding of other naturally infected species may indicate that secondary vectors are also involved in the transmission of malaria in the study areas. these findings can be expected to help in the implementation of new measures to control autochthonous malaria in areas of the atlantic forest. © 2013 duarte et al.; licensee biomed central ltd.